220 related articles for article (PubMed ID: 1709168)
1. The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers.
Dvir A; Milner Y; Chomsky O; Gilon C; Gazit A; Levitzki A
J Cell Biol; 1991 May; 113(4):857-65. PubMed ID: 1709168
[TBL] [Abstract][Full Text] [Related]
2. Effect of tyrphostin on cell growth and tyrosine kinase activity of epidermal growth factor receptor in human gliomas.
Miyaji K; Tani E; Shindo H; Nakano A; Tokunaga T
J Neurosurg; 1994 Sep; 81(3):411-9. PubMed ID: 8057149
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor signaling cascade as target for tyrphostin (RG 50864) in epithelial cells. Paradoxical effects on mitogen-activated protein kinase kinase and mitogen-activated protein kinase activities.
Nowak F; Jacquemin-Sablon A; Pierre J
Biochem Pharmacol; 1997 Feb; 53(3):287-98. PubMed ID: 9065732
[TBL] [Abstract][Full Text] [Related]
4. Tyrphostins inhibit epidermal growth factor (EGF)-receptor tyrosine kinase activity in living cells and EGF-stimulated cell proliferation.
Lyall RM; Zilberstein A; Gazit A; Gilon C; Levitzki A; Schlessinger J
J Biol Chem; 1989 Aug; 264(24):14503-9. PubMed ID: 2788167
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor-specific protein tyrosine phosphorylation in preimplantation embryo development.
Paria BC; Tsukamura H; Dey SK
Biol Reprod; 1991 Nov; 45(5):711-8. PubMed ID: 1721842
[TBL] [Abstract][Full Text] [Related]
6. Tyrphostins suppress the growth of psoriatic keratinocytes.
Ben-Bassat H; Vardi DV; Gazit A; Klaus SN; Chaouat M; Hartzstark Z; Levitzki A
Exp Dermatol; 1995 Apr; 4(2):82-8. PubMed ID: 7640880
[TBL] [Abstract][Full Text] [Related]
7. Rapid uptake of tyrphostin into A431 human epidermoid cells is followed by delayed inhibition of epidermal growth factor (EGF)-stimulated EGF receptor tyrosine kinase activity.
Faaland CA; Mermelstein FH; Hayashi J; Laskin JD
Mol Cell Biol; 1991 May; 11(5):2697-703. PubMed ID: 1850101
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors.
Gillespie J; Dye JF; Schachter M; Guillou PJ
Br J Cancer; 1993 Dec; 68(6):1122-6. PubMed ID: 8260363
[TBL] [Abstract][Full Text] [Related]
9. Activation of the mitogen-activated protein kinase cascade by tyrphostin (RG 50864).
Agbotounou WK; Mousset S; Piperno S; Pierre M; Jacquemin-Sablon A; Pierre J
Biochem Pharmacol; 1994 Aug; 48(3):505-15. PubMed ID: 8068037
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine kinase inhibitors and the contractile action of epidermal growth factor-urogastrone and other agonists in gastric smooth muscle.
Yang SG; Saifeddine M; Hollenberg MD
Can J Physiol Pharmacol; 1992 Jan; 70(1):85-93. PubMed ID: 1316219
[TBL] [Abstract][Full Text] [Related]
11. Ultraviolet B injury increases prostaglandin synthesis through a tyrosine kinase-dependent pathway. Evidence for UVB-induced epidermal growth factor receptor activation.
Miller CC; Hale P; Pentland AP
J Biol Chem; 1994 Feb; 269(5):3529-33. PubMed ID: 8106395
[TBL] [Abstract][Full Text] [Related]
12. Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation.
Peterson G; Barnes S
Prostate; 1993; 22(4):335-45. PubMed ID: 8497428
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cardiac adenylyl cyclase by epidermal growth factor (EGF). Role of EGF receptor protein tyrosine kinase activity.
Nair BG; Patel TB
Biochem Pharmacol; 1993 Oct; 46(7):1239-45. PubMed ID: 8216375
[TBL] [Abstract][Full Text] [Related]
14. Regulation of TGF-alpha expression in human keratinocytes: PKC-dependent and -independent pathways.
Klein SB; Fisher GJ; Jensen TC; Mendelsohn J; Voorhees JJ; Elder JT
J Cell Physiol; 1992 May; 151(2):326-36. PubMed ID: 1572907
[TBL] [Abstract][Full Text] [Related]
15. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
Brunton VG; Carlin S; Workman P
Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinase activity is necessary for growth factor-stimulated rabbit type II pneumocyte proliferation.
Chess PR; Ryan RM; Finkelstein JN
Pediatr Res; 1994 Oct; 36(4):481-6. PubMed ID: 7529394
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of EGF-induced vasoconstriction in isolated rabbit aortic rings with the tyrosine kinase inhibitor RG50864.
Merkel LA; Rivera LM; Colussi DJ; Perrone MH
Biochem Biophys Res Commun; 1993 May; 192(3):1319-26. PubMed ID: 7685166
[TBL] [Abstract][Full Text] [Related]
18. Tyrphostins inhibit the epidermal growth factor receptor-mediated breakdown of phosphoinositides.
Posner I; Gazit A; Gilon C; Levitzki A
FEBS Lett; 1989 Nov; 257(2):287-91. PubMed ID: 2555218
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cells.
Sion-Vardy N; Vardy D; Rodeck U; Kari C; Levin RM; Malkowicz SB
J Surg Res; 1995 Dec; 59(6):675-80. PubMed ID: 8538164
[TBL] [Abstract][Full Text] [Related]
20. The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factor.
Ohmichi M; Pang L; Ribon V; Gazit A; Levitzki A; Saltiel AR
Biochemistry; 1993 May; 32(17):4650-8. PubMed ID: 7683492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
